Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Apr 19, 2024
- Accession no.
- 0001415889-24-011252
- Filed
- Apr 19, 2024
- Trade date
- Apr 17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $153.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | Common Stock | MOption exerciseAcquired | +6,853 | $2.14 | +$14,665.42 | 8,144 | Direct | |
| Apr 17, 2024 | Common Stock | SSaleDisposed | −6,447 | $22.32 | −$143,897.04 | 1,697 | Direct | |
| Apr 17, 2024 | Common Stock | SSaleDisposed | −338 | $23.17 | −$7,831.46 | 1,359 | Direct | |
| Apr 17, 2024 | Common Stock | SSaleDisposed | −68 | $23.97 | −$1,629.96 | 1,291 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | Common Stock | MOption exerciseDisposed | −6,853 | $0.00 | $0 | 95,936 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.